Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05974202 · ClinicalTrials.gov registry record · NA
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
A NA study, sponsored by New York State Psychiatric Institute.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05974202 is a NA study that has not yet begun recruiting, run by New York State Psychiatric Institute. The registered enrollment target is 30 participants.
The verdict
NCT05974202, a NA study, has not yet begun recruiting, sponsored by New York State Psychiatric Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare the effects of active repetitive transcranial magnetic stimulation (rTMS) to sham (placebo) rTMS prior to cognitive-behavioral therapy (CBT) as a treatment for adults with cocaine use disorder. The main questions it aims to answer are: * Is rTMS safe and feasible as an augmentation for CBT for the treatment of cocaine use disorder? * What is the brain mechanism of rTMS? * Will active rTMS (compared to sham rTMS) followed by CBT help adults with cocaine use disorder achieve abstinence from cocaine? Participants will: * Have two brain MRI scans; * Undergo 3 weeks of daily rTMS (or sham) treatments (15 sessions), and; * Have 12 weeks of once-weekly cognitive-behavioral therapy for the treatment of cocaine use disorder. Researchers will compare active (real) rTMS to sham (placebo) rTMS. All participants will receive cognitive-behavioral therapy. The former principle investigator, Dr. Derek Blevins, has vacated his position (February 2025), and has transferred the principle investigator role to Dr. John Mariani, the STARS Clinic Director.
Interventions
- DEVICE Active H7-coil repetitive transcranial magnetic stimulation (rTMS)
- DEVICE Sham H7-coil repetitive transcranial magnetic stimulation (rTMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05974202
The ClinicalTrials.gov registry entry for NCT05974202 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active H7-coil repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT05974202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05974202 about?
NCT05974202 is a clinical study titled "rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder". The goal of this clinical trial is to compare the effects of active repetitive transcranial magnetic stimulation (rTMS) to sham (placebo) rTMS prior to cognitive-behavioral therapy (CBT) as a treatment for adults with cocaine use disorder. The main questions it aims to answer are: * Is rTMS safe an...
What is the current status of trial NCT05974202?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-05-01. Estimated completion is 2028-04-28.
What interventions are being tested in trial NCT05974202?
The interventions under investigation include: Active H7-coil repetitive transcranial magnetic stimulation (rTMS) (DEVICE), Sham H7-coil repetitive transcranial magnetic stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT05974202?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.